Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Jun 29;13:6191–6202. doi: 10.2147/OTT.S253861

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 Chen et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

UBE2O promotes HNSCC tumor growth in vivo. (A and B) The UBE2O KO tumor xenografts grew substantially more slowly than those in the control group. (C) The average weight of the tumors in the UBE2O KO group was significantly lighter than that in the control group. (D) UBE2O affected the mRNA levels of EMT biomarkers in the xenograft tumors. (E) UBE2O affected the protein levels of EMT biomarkers in the xenograft tumors. (F) UBE2O affected the mRNA levels of angiogenesis biomarkers in the xenograft tumors (*P < 0.05, ***P < 0.001).